A nonischemic electrocardiogram does not always predict a small myocardial infarction: Results with acute myocardial perfusion imaging

American Heart Journal

Volumn 141, Issue 3, 2001, Pages 360-366

  Kontos, Michael C ^a   Kurdziel, Karen A ^a   Ornato, Joseph P ^a   Schmidt, Kristin L ^a   Jesse, Robert L ^a   Tatum, James L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; T WAVE;

EID: 0035091789     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.113079     Document Type: Article

References (31)

1. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study)
2. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients
3. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile
4. Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain
5. Comprehensive strategy for the evaluation and triage of the chest pain patient
6. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction: GUSTO-I investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries
7. The entry ECG in the early diagnosis and prognostic stratification of patients with suspected acute myocardial infarction
8. Usefulness of the 12-lead electrocardiogram in detection of myocardial infarction: Electrocardiographic-anatomic correlations, II
9. Ventricular function and infarct size: The Western Washington Intravenous Streptokinase in Myocardial Infarction Trial
10. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge
11. Coronary anatomy and left ventricular function in the first 12 hours of acute myocardial infarction: The Western Washington Randomized Intracoronary Streptokinase Trial
12. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
13. A comprehensive analysis of myocardial infarction due to left circumflex artery occlusion: Comparison with infarction due to right coronary artery and left anterior descending artery occlusion
14. Electrocardiographic differentiation of the ST-segment depression of acute myocardial injury due to the left circumflex artery occlusion from that of myocardial ischemia of nonocclusive etiologies
15. Noninvasive identificatian of myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiograms with technetium-99m-sestamibi
16. Intracoronary electrocardiogram during coronary angioplasty
17. Surface electrocardiogram in the detection of transmural myocardial ischemia during coronary artery occlusion
18. Do patients with left circumflex coronary artery-related acute myocardial infarction without ST-segment elevation benefit from reperfusion therapy?
19. Variability of myocardium at risk for acute myocardial infarction
20. Residual flow to the infarct zone as a determinant of infarct size after direct angioplasty
21. Comparison using dynamic vectorcardiography and MIBI SPECT of ST-segment changes and myocardial MIBI uptake during percutaneous transluminal coronary angioplasty of the left anterior descending coronary artery
22. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile
23. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: Efficacy for noninvasive assessment of thrombolytic therapy
24. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction
25. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile
26. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction
27. Single photon emission computed tomography with technetium-99m hexakis 2-methoxy-isobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: Assessment of salvaged myocardium and prediction of late functional recovery
28. Technetium-99m methoxy-isobutyl isonitrile (RP30) for quantification of myocardial ischemia and reperfusion in dogs
29. In vitro validation of a simple tomographic technique for estimation of percent myocardium "at risk" using techentium-99m methoxy isobutyl isonitrile (sestamibi)
30. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT